Heartwire - Episode 148: EVINCI: Invasive diagnostic tests can be dramatically reduced; cardiologists react to Supreme Court decision on ACA; readmission rates after MI not the best quality indicator?; rosiglitazone in healthcare-fraud case; 10-minute ech

Summary: For the week ending July 6, 2012 we discuss the following top cardiology news from heartwire: • EVINCI: Invasive diagnostic tests can be dramatically reduced • "Thrilled," "stunned," "full of hope": Reactions to Supreme Court decision • Readmission rates after MI not the best quality indicator? • Rosiglitazone features in $3-billion healthcare-fraud case • Ten-minute, abbreviated echo can be added to young athlete screening And also, in brief: • Coffee vs heart failure: A few cups per day protects • Half of ACS, HF patients suffer medication errors despite pharmacist intervention • Tighter UK food policies could slash CV deaths by 30 000 Join us for a comprehensive review of this week's most important cardiology news.